109051 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against viruses against herpetoviridae, e.g. HSV
RNA GUIDED ERADICATION OF HERPES SIMPLEX TYPE I AND OTHER RELATED HERPESVIRUSES
#2Treating herpesvirus-mediated intestinal dysfunction for prevention of age-related neurodegeneration
#3ONCOLYTIC VIRUS EXPRESSING AN IMMUNE CELL ENGAGER FOR TUMOR TARGETING
#4METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS
#5CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)
#6COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
#7Oligomers and oligomer conjugates
#8METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS
#9GAMMA HERPESVIRUS CIRCULAR RNA
#10RNA GUIDED ERADICATION OF VARICELLA ZOSTER VIRUS
#11ONCOLYTIC VIRAL VECTORS AND USES THEREOF
#12COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#13Method for delivering RNA to neurons to treat herpes infections
#14COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
#15TARGETS AND METHODS FOR TREATING EPSTEIN-BARR VIRUS MEDIATED NEURODEGENERATION
#16Compositions and methods for the targeting of SOD1
#17CRISPR/CAS-related methods and compositions for treating herpes simplex virus
#18COMPOSITIONS FOR HERPESVIRUS TRANSCRIPTIONAL FEEDBACK CIRCUIT DISRUPTION AND USES THEREOF
#19Gamma herpesvirus circular RNA
#20TREATING HERPESVIRUS-MEDIATED INTESTINAL DYSFUNCTION FOR PREVENTION OF AGE-RELATED NEURODEGENERATION
#21ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
#22Oligomers and oligomer conjugates
#23NONTOXIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF HERPESVIRUS INFECTIONS
#24Epstein Barr virus antibodies, vaccines, and uses of the same
#25Oncolytic viral vectors and uses thereof
#26COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#27Oligomers and oligomer conjugates
#28Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#29COMPOSITIONS FOR THE INACTIVATION OF VIRUS REPLICATION AND METHODS OF MAKING AND USING THE SAME
#30CRISPR/cas-related methods and compositions for treating herpes simplex virus
#31Nontoxic compounds for the treatment and prevention of herpesvirus infections
#32Method for delivering RNA to neurons to treat herpes infections
#33Production of viruses in avian eggs
#34Compositions and Methods of Delivering Treatments for Latent Viral Infections
#35Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#36Antisense antibacterial compounds and methods
#37Managing Intercellular Communications
#38Production of viruses in avian eggs
#39Oncolytic viral vectors and uses thereof
#40CRISPR/Cas-related methods and compositions for treating herpes simplex virus
#41LENTIVIRUS AND NON-INTEGRATING LENTIVIRUS AS VIRAL VECTOR TO DELIVER CRISPR THERAPEUTIC
#42Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#43ANTIVIRAL NUCLEASE METHODS
#44Use of the chromosome 19 microRNA cluster (C19MC) for treating microbial disease and promoting authophagy
#45Compositions and Methods of Delivering Treatments for Latent Viral Infections
#46Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#47CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)
#48Compositions for the inactivation of virus replication and methods of making and using the same
#49Oligomers and oligomer conjugates
#50NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION
#51Compositions and methods to treat latent viral infections
#52Compositions and methods of delivering treatments for latent viral infections
#53COMPOSITION FOR TREATING EPSTEIN-BARR VIRUS INFECTION, COMPRISING EPSTEIN-BARR VIRUS MICRO RNA INHIBITOR
#54Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#55Method to treat or prevent herpesvirus infections
#56RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#57Use of the chromosome 19 microRNA cluster (C19MC) for treating viral disease and promoting authophagy
#58CMV GENE PRODUCTS PROMOTE CANCER STEM CELL GROWTH
#59Replication capable rAAV vectors encoding inhibitory siRNA and methods of their use
#60CMV gene products promote cancer stem cell growth
#61Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#62siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES
#63Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections
#64Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#65Viral microRNA
#66Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections
#67Nucleic acids involved in viral infection
#68METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#69METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#70RNA interference and disease resistance in avians
#71COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION
#72Small interfering RNAs targeting feline herpes virus
#73COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HUMAN HERPESVIRUS (HHV)-6
#74Herpesvirus ribozymes and vectors
#75siRNA microbicides for preventing and treating diseases
#76Treatment of HSV-related pathologies using plasmids that make ssDNA
#77RNA interference and disease resistance in avians
#78Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
#79Methods and compositions for inhibiting the function of polynucleotide sequences
#80miRNA of HSV-LAT and uses thereof
#81Modulation of telomere length by oligonucleotides having a G-core sequence
#82Methods and compositions for inhibiting the function of polynucleotide sequences
#83Methods and compositions for inhibiting the function of polynucleotide sequences
#84Methods and compositions for inhibiting the function of polynucleotide sequences
#85Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
#86Antiviral oligonucleotides having a conserved G4 core sequence
#87Methods and compositions for inhibiting the function of polynucleotide sequences
#88RNA interference in avians
#89Methods and compositions for inhibiting the function of polynucleotide sequences
#90Immune stimulation by phosphorothioate oligonucleotide analogs
#91Oligonucleotide complexes for use as anti-viral therapeutics